HighTower Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $93.8M | Sell |
475,948
-6,676
| -1% | -$1.29M | 0.1% | 204 |
|
|
2025
Q4 | $88.7M | Buy |
482,624
+3,506
| +0.7% | +$615K | 0.1% | 214 |
|
|
2025
Q3 | $73.5M | Buy |
479,118
+15,979
| +3% | +$2.42M | 0.08% | 243 |
|
|
2025
Q2 | $64.7M | Buy |
463,139
+90,340
| +24% | +$12.7M | 0.08% | 258 |
|
|
2025
Q1 | $54.8M | Buy |
372,799
+17,486
| +5% | +$2.53M | 0.07% | 275 |
|
|
2024
Q4 | $46.6M | Sell |
355,313
-8,020
| -2% | -$1.12M | 0.06% | 299 |
|
|
2024
Q3 | $56.6M | Sell |
363,333
-3,677
| -1% | -$594K | 0.08% | 251 |
|
|
2024
Q2 | $57.2M | Buy |
367,010
+16,817
| +5% | +$2.53M | 0.09% | 237 |
|
|
2024
Q1 | $47.4M | Buy |
350,193
+13,551
| +4% | +$1.79M | 0.08% | 262 |
|
|
2023
Q4 | $45.3M | Buy |
336,642
+9,720
| +3% | +$1.26M | 0.08% | 262 |
|
|
2023
Q3 | $44.3M | Buy |
326,922
+189,301
| +138% | +$25.9M | 0.08% | 238 |
|
|
2023
Q2 | $19.7M | Buy |
137,621
+24,409
| +22% | +$3.59M | 0.04% | 435 |
|
|
2023
Q1 | $15.7M | Buy |
113,212
+9,711
| +9% | +$1.31M | 0.03% | 479 |
|
|
2022
Q4 | $14M | Sell |
103,501
-4,441
| -4% | -$557K | 0.03% | 502 |
|
|
2022
Q3 | $11.9M | Buy |
107,942
+13,300
| +14% | +$1.69M | 0.03% | 505 |
|
|
2022
Q2 | $12.5M | Buy |
94,642
+24,963
| +36% | +$3.28M | 0.03% | 493 |
|
|
2022
Q1 | $9.25M | Sell |
69,679
-31,695
| -31% | -$3.8M | 0.02% | 653 |
|
|
2021
Q4 | $11.8M | Buy |
101,374
+3,041
| +3% | +$358K | 0.03% | 542 |
|
|
2021
Q3 | $11.8M | Buy |
98,333
+18,423
| +23% | +$2.14M | 0.03% | 479 |
|
|
2021
Q2 | $9.58M | Buy |
79,910
+18,820
| +31% | +$2.06M | 0.03% | 534 |
|
|
2021
Q1 | $6.01M | Buy |
61,090
+9,109
| +18% | +$916K | 0.02% | 677 |
|
|
2020
Q4 | $5.15M | Buy |
51,981
+13,065
| +34% | +$1.38M | 0.02% | 582 |
|
|
2020
Q3 | $4.25M | Buy |
38,916
+13,367
| +52% | +$1.49M | 0.02% | 608 |
|
|
2020
Q2 | $2.7M | Sell |
25,549
-671
| -3% | -$69.3K | 0.01% | 704 |
|
|
2020
Q1 | $2.34M | Buy |
+26,220
| New | +$2.47M | 0.02% | 701 |
|
|
2019
Q4 | – | Sell |
-28,339
| Closed | -$2.52M | – | 2351 |
|
|
2019
Q3 | $2.52M | Buy |
28,339
+3,701
| +15% | +$321K | 0.01% | 813 |
|
|
2019
Q2 | $2.03M | Sell |
24,638
-1,787
| -7% | -$140K | 0.01% | 894 |
|
|
2019
Q1 | $2.13M | Sell |
26,425
-2,376
| -8% | -$187K | 0.01% | 830 |
|
|
2018
Q4 | $2.19M | Sell |
28,801
-746
| -3% | -$58.3K | 0.02% | 731 |
|
|
2018
Q3 | $2.35M | Sell |
29,547
-29,335
| -50% | -$2.22M | 0.02% | 782 |
|
|
2018
Q2 | $4.14M | Sell |
58,882
-3,106
| -5% | -$223K | 0.03% | 556 |
|
|
2018
Q1 | $4.33M | Sell |
61,988
-3,971
| -6% | -$275K | 0.04% | 514 |
|
|
2017
Q4 | $4.57M | Sell |
65,959
-7,218
| -10% | -$487K | 0.04% | 503 |
|
|
2017
Q3 | $4.96M | Buy |
73,177
+4,963
| +7% | +$314K | 0.04% | 464 |
|
|
2017
Q2 | $4.64M | Sell |
68,214
-25,521
| -27% | -$1.67M | 0.04% | 490 |
|
|
2017
Q1 | $5.83M | Sell |
93,735
-4,227
| -4% | -$246K | 0.06% | 380 |
|
|
2016
Q4 | $5.35M | Sell |
97,962
-52,772
| -35% | -$3M | 0.06% | 367 |
|
|
2016
Q3 | $9.91M | Sell |
150,734
-10,890
| -7% | -$712K | 0.11% | 179 |
|
|
2016
Q2 | $9.76M | Sell |
161,624
-114,028
| -41% | -$6.62M | 0.12% | 173 |
|
|
2016
Q1 | $15.5M | Buy |
275,652
+11,501
| +4% | +$691K | 0.05% | 137 |
|
|
2015
Q4 | $17.9M | Sell |
264,151
-129,318
| -33% | -$8.48M | 0.21% | 106 |
|
|
2015
Q3 | $25.1M | Buy |
+393,469
| New | +$25.9M | 0.33% | 63 |
|
|
2015
Q2 | – | Sell |
-321,172
| Closed | -$22M | – | 1560 |
|
|
2015
Q1 | $22M | Buy |
321,172
+48,854
| +18% | +$3.39M | 0.33% | 62 |
|
|
2014
Q4 | $19.2M | Buy |
272,318
+130,721
| +92% | +$9.36M | 0.29% | 75 |
|
|
2014
Q3 | $10.1M | Sell |
141,597
-25,514
| -15% | -$1.87M | 0.17% | 136 |
|
|
2014
Q2 | $12.4M | Buy |
167,111
+155,133
| +1,295% | +$11.2M | 0.22% | 101 |
|
|
2014
Q1 | $777K | Sell |
11,978
-3,118
| -21% | -$201K | 0.02% | 824 |
|
|
2013
Q4 | $896K | Sell |
15,096
-87,049
| -85% | -$4.73M | 0.02% | 743 |
|
|
2013
Q3 | $5.32M | Buy |
102,145
+8,589
| +9% | +$431K | 0.13% | 182 |
|
|
2013
Q2 | $4.42M | Buy |
+93,556
| New | +$4.76M | 0.12% | 194 |
|
Other funds holding AZN
IA
VCM
VAM
HighTower Advisors's AZN Position: Q1 2026 in Review
HighTower Advisors reduced its AstraZeneca (AZN) stake by 1.4% in Q1 2026, selling an estimated $1.29M and leaving 475,948 shares worth $93.8M. The position accounts for 0.1% of the portfolio, ranked #204.
HighTower Advisors first reported a position in AZN in Q2 2013 and has held it in 50 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- HighTower Advisors held 475,948 shares of AstraZeneca worth $93.8M as of Q1 2026.
- HighTower Advisors sold 6,676 AstraZeneca shares in Q1 2026, an estimated $1.29M.
- AstraZeneca made up 0.1% of HighTower Advisors's portfolio in Q1 2026, its #204 holding.
- HighTower Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 50 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.